Literature DB >> 21554858

Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose.

Huanyu Ju1, Na Wei, Qian Wang, Chunyuan Wang, Zhiqiang Jing, Lu Guo, Dapeng Liu, Mingchun Gao, Bo Ma, Junwei Wang.   

Abstract

Goose parvovirus (GPV), a small non-enveloped ssDNA virus, can cause Derzsy's disease, and three capsid proteins of VP1, VP2, and VP3 are encoded by an overlapping nucleotide sequence. However, little is known on whether recombinant viral proteins (VPs) could spontaneously assemble into virus-like particles (VLPs) in insect cells and whether these VLPs could retain their immunoreactivity and immunogenicity in susceptible geese. To address these issues, genes for these GPV VPs were amplified by PCR, and the recombinant VPs proteins were expressed in insect cells using a baculovirus expression system for the characterization of their structures, immunoreactivity, and immunogenicity. The rVP1, rVP2, and rVP3 expressed in Sf9 cells were detected by anti-GPV sera, anti-VP3 sera, and anti-His antibodies, respectively. Electron microscopy revealed that these rVPs spontaneously assembled into VLPs in insect cells, similar to that of the purified wild-type GPV virions. In addition, vaccination with individual types of VLPs, particularly with the rVP2-VLPs, induced higher titers of antibodies and neutralized different strains of GPVs in primary goose and duck embryo fibroblast cells in vitro. These data indicated that these VLPs retained immunoreactivity and had strong immunogenicity in susceptible geese. Therefore, our findings may provide a framework for development of new vaccines for the prevention of Derzsy's disease and vehicles for the delivery of drugs.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554858     DOI: 10.1016/j.bbrc.2011.04.129

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Generation and characterization of polyclonal antibody against part of immunoglobulin constant heavy υ chain of goose.

Authors:  Panpan Zhao; Yongli Guo; Bo Ma; Mingwei Xing; Junwei Wang
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-08

2.  Chimeric calicivirus-like particles elicit specific immune responses in pigs.

Authors:  E Crisci; L Fraile; N Moreno; E Blanco; R Cabezón; C Costa; T Mussá; M Baratelli; P Martinez-Orellana; L Ganges; J Martínez; J Bárcena; M Montoya
Journal:  Vaccine       Date:  2012-02-03       Impact factor: 3.641

Review 3.  Virus-like particles: the new frontier of vaccines for animal viral infections.

Authors:  Elisa Crisci; Juan Bárcena; María Montoya
Journal:  Vet Immunol Immunopathol       Date:  2012-06-01       Impact factor: 2.046

4.  Generation and evaluation of a recombinant genotype VII Newcastle disease virus expressing VP3 protein of Goose parvovirus as a bivalent vaccine in goslings.

Authors:  Jianzhong Wang; Yanlong Cong; Renfu Yin; Na Feng; Songtao Yang; Xianzhu Xia; Yueqiang Xiao; Wenxiu Wang; Xiufan Liu; Shunlin Hu; Chan Ding; Shengqing Yu; Chunfeng Wang; Zhuang Ding
Journal:  Virus Res       Date:  2015-04-13       Impact factor: 3.303

5.  Characterization of monoclonal antibodies against waterfowl parvoviruses VP3 protein.

Authors:  Xiuchen Yin; Shumei Zhang; Youlan Gao; Jinzhe Li; Shuyi Tan; Hongyu Liu; Xiaoying Wu; Yuhuan Chen; Ming Liu; Yun Zhang
Journal:  Virol J       Date:  2012-11-23       Impact factor: 4.099

Review 6.  Role of capsid proteins in parvoviruses infection.

Authors:  Mengyu Tu; Fei Liu; Shun Chen; Mingshu Wang; Anchun Cheng
Journal:  Virol J       Date:  2015-08-04       Impact factor: 4.099

Review 7.  Subviral particle as vaccine and vaccine platform.

Authors:  Ming Tan; Xi Jiang
Journal:  Curr Opin Virol       Date:  2014-03-21       Impact factor: 7.090

8.  A Conserved Epitope Mapped with a Monoclonal Antibody against the VP3 Protein of Goose Parvovirus by Using Peptide Screening and Phage Display Approaches.

Authors:  Chenxi Li; Hongyu Liu; Jinzhe Li; Dafei Liu; Runze Meng; Qingshan Zhang; Wulin Shaozhou; Xiaofei Bai; Tingting Zhang; Ming Liu; Yun Zhang
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

Review 9.  Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems.

Authors:  Zeinab Shirbaghaee; Azam Bolhassani
Journal:  Biopolymers       Date:  2016-03       Impact factor: 2.505

Review 10.  Virus-like particle-based vaccines for animal viral infections.

Authors:  Elisa Crisci; Juan Bárcena; María Montoya
Journal:  Inmunologia       Date:  2012-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.